Literature DB >> 9854059

Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum.

J A Comer1, W L Nicholson, J W Sumner, J G Olson, J E Childs.   

Abstract

A PCR assay of 43 acute-phase serum samples was evaluated as a method for early detection of human granulocytic ehrlichiosis (HGE) and determination of etiology when serologic testing is inconclusive. Sequence-confirmed products of the HGE agent were amplified from three individuals residing or having exposure history in Minnesota or Wisconsin, and similarly confirmed products from Ehrlichia chaffeensis were amplified from three individuals from Florida or Maryland. Etiology, as determined by PCR and serology, was the same whenever there was a fourfold difference between the maximum titers of antibodies to both antigens, indicating that presumptive determination of etiology may be based on fourfold differences in titers. PCR testing determined that E. chaffeensis was the etiologic agent for one individual who had similar titers of antibodies to both agents. PCR assay of acute-phase serum in the absence of whole blood specimens may be a useful method for early detection of human ehrlichiosis and determination of etiology when serologic testing is inconclusive.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854059      PMCID: PMC84159     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis.

Authors:  C D Paddock; J W Sumner; G M Shore; D C Bartley; R C Elie; J G McQuade; C R Martin; C S Goldsmith; J E Childs
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

3.  An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis.

Authors:  W L Nicholson; J A Comer; J W Sumner; C Gingrich-Baker; R T Coughlin; L A Magnarelli; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

5.  Influence of volume of sample processed on detection of Chlamydia trachomatis in urogenital samples by PCR.

Authors:  W H Goessens; J A Kluytmans; N den Toom; T H van Rijsoort-Vos; B G Niesters; E Stolz; H A Verbrugh; W G Quint
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

6.  Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction.

Authors:  B E Anderson; J W Sumner; J E Dawson; T Tzianabos; C R Greene; J G Olson; D B Fishbein; M Olsen-Rasmussen; B P Holloway; E H George
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Human ehrlichiosis in Florida.

Authors:  M H Rathore; K Meyer
Journal:  J Fla Med Assoc       Date:  1993-05

8.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

9.  Human ehrlichiosis in the United States, 1985 to 1990.

Authors:  D B Fishbein; J E Dawson; L E Robinson
Journal:  Ann Intern Med       Date:  1994-05-01       Impact factor: 25.391

10.  Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence.

Authors:  J S Dumler; J S Bakken
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

View more
  7 in total

1.  Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance.

Authors:  J E Childs; J W Sumner; W L Nicholson; R F Massung; S M Standaert; C D Paddock
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens.

Authors:  A Unver; Y Rikihisa; N Ohashi; L C Cullman; R Buller; G A Storch
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients.

Authors:  Eun-jeong Heo; Jin-ho Park; Ja-ryong Koo; Man-suk Park; Mi-yeoun Park; J Stephen Dumler; Joon-seok Chae
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

5.  Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting.

Authors:  Juan P Olano; Wayne Hogrefe; Brent Seaton; David H Walker
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

6.  Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: importance of infection time course for optimal test utilization.

Authors:  A M Schotthoefer; J K Meece; L C Ivacic; P D Bertz; K Zhang; T Weiler; T S Uphoff; T R Fritsche
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

7.  Human monocytotropic ehrlichiosis, Missouri.

Authors:  Juan P Olano; Edwin Masters; Wayne Hogrefe; David H Walker
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.